Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
World J Gastroenterol
; 25(33): 4945-4958, 2019 Sep 07.
Article
em En
| MEDLINE
| ID: mdl-31543685
ABSTRACT
BACKGROUND:
Carcinoembryonic antigen (CEA) is a commonly used biomarker in colorectal cancer. However, controversy exists regarding the insufficient prognostic value of preoperative serum CEA alone in rectal cancer. Here, we combined preoperative serum CEA and the maximum tumor diameter to correct the CEA level, which may better reflect the malignancy of rectal cancer.AIM:
To assess the prognostic impact of preoperative CEA/tumor size in rectal cancer.METHODS:
We retrospectively reviewed 696 stage I to III rectal cancer patients who underwent curative tumor resection from 2007 to 2012. These patients were randomly divided into two cohorts for cross-validation training cohort and validation cohort. The training cohort was used to generate an optimal cutoff point and the validation cohort was used to further validate the model. Maximally selected rank statistics were used to identify the optimum cutoff for CEA/tumor size. The Kaplan-Meier method and log-rank test were used to plot the survival curve and to compare the survival data. Univariate and multivariate Cox regression analyses were used to determine the prognostic value of CEA/tumor size. The primary and secondary outcomes were overall survival (OS) and disease-free survival (DFS), respectively.RESULTS:
In all, 556 patients who satisfied both the inclusion and exclusion criteria were included and randomly divided into the training cohort (2/3 of 556, n = 371) and the validation cohort (1/3 of 556, n = 185). The cutoff was 2.429 ng/mL per cm. Comparison of the baseline data showed that high CEA/tumor size was correlated with older age, high TNM stage, the presence of perineural invasion, high CEA, and high carbohydrate antigen 19-9 (CA 19-9). Kaplan-Meier curves showed a manifest reduction in 5-year OS (training cohort 56.7% vs 81.1%, P < 0.001; validation cohort 58.8% vs 85.6%, P < 0.001) and DFS (training cohort 52.5% vs 71.9%, P = 0.02; validation cohort 50.3% vs 79.3%, P = 0.002) in the high CEA/tumor size group compared with the low CEA/tumor size group. Univariate and multivariate analyses identified CEA/tumor size as an independent prognostic factor for OS (training cohort hazard ratio (HR) = 2.18, 95% confidence interval (CI) 1.28-3.73, P = 0.004; validation cohort HR = 4.83, 95%CI 2.21-10.52, P < 0.001) as well as DFS (training cohort HR = 1.47, 95%CI 0.93-2.33, P = 0.096; validation cohort HR = 2.61, 95%CI 1.38-4.95, P = 0.003).CONCLUSION:
Preoperative CEA/tumor size is an independent prognostic factor for patients with stage I-III rectal cancer. Higher CEA/tumor size is associated with worse OS and DFS.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Retais
/
Reto
/
Antígeno Carcinoembrionário
/
Carga Tumoral
/
Protectomia
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
World J Gastroenterol
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
China